On 14 de nov. de 2025, NNVC reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.18 USD, resulting in a 45.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.82% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analistas forecast an EPS of -0.14 USD, with revenue projected to reach -- USD, implying an aumentar of 40.00% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were NanoViricides Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, NanoViricides Inc. reported EPS of -$0.10, beating estimates by 45.53%, and revenue of $0.00, 0% as expectations.
How did the market react to NanoViricides Inc.'s Q1 2026 earnings?
The stock price moved up 2.82%, changed from $1.42 before the earnings release to $1.46 the day after.
When is NanoViricides Inc. expected to report next?
The next earning report is scheduled for 12 de fev. de 2026.
What are the forecasts for NanoViricides Inc.'s next earnings report?
Based on 4
analistas, NanoViricides Inc. is expected to report EPS of -$0.14 and revenue of -- for Q2 2026.